Pharmabiz2m
EMA’s veterinary committee issues first certificate for vaccine platform technology master file
EMA's Committee for Veterinary Medicinal Products (CVMP) has issued the first certificate for a vaccine platform technology master file (vPTMF) which will support and accelerate the development and ...
Pharmabiz1h
Daiichi Sankyo & AstraZeneca’s Enhertu receives 2024 Prix Galien USA Award for Best Biotechnology Product
Daiichi Sankyo & AstraZeneca’s Enhertu receives 2024 Prix Galien USA Award for Best Biotechnology Product: Tokyo Monday, November 11, 2024, 09:00 Hrs [IST] Daiichi Sankyo and As ...
Pharmabiz2h
MSMEs in confusion as govt is keeping mum on demand for extending implementation of revised Schedule M
Peethaambaran Kunnathoor, Chennai Monday, November 11, 2024, 08:00 Hrs [IST] ...
Pharmabiz2h
DGTR releases list of registered parties on anti-dumping investigation on sodium citrate imports from China
DGTR releases list of registered parties on anti-dumping investigation on sodium citrate imports from China: Shardul Nautiyal, Mumbai Monday, November 11, 2024, 08:00 Hrs [IST] Th ...
Pharmabiz2h
Ayush and herbal products exports grow over 10 per cent in H1 FY25
Exports of Ayush and herbal products for the first six months of the current fiscal has reported a 10.34 per cent growth, as ...
Pharmabiz2h
Karnataka Ayush sector upbeat on recent amendment to renew manufacturing & loan licenses to perpetuity
The recent amendments brought by the Union Ministry of Ayush to the Drugs and Cosmetics Rules, 1945 are significant, as they introduce new regulatory requirements for the manufacturing and sale of ...
Pharmabiz2h
Centre notifies rules for recruitment of medical device officers in CDSCO
Centre notifies rules for recruitment of medical device officers in CDSCO: Gireesh Babu, New Delhi Monday, November 11, 2024, 08:00 Hrs [IST] In an effort to strengthen the regula ...
Pharmabiz1d
SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting
SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting: Stamford, Connecticut Saturday, N ...
Pharmabiz1d
Dizal seeks US FDA approval for sunvozertinib to treat relapsed or refractory NSCLC with EGFR Exon 20 insertion mutations
Dizal seeks US FDA approval for sunvozertinib to treat relapsed or refractory NSCLC with EGFR Exon 20 insertion mutations: Shanghai, China Saturday, November 9, 2024, 17:00 Hrs [I ...
Pharmabiz1d
Serres Group receives €1.8 million research grant from Business Finland
Serres Group receives €1.8 million research grant from Business Finland: Espoo, Finland Saturday, November 9, 2024, 16:00 Hrs [IST] Serres has been granted a substantial researc ...
Pharmabiz1d
Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma
Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma: Seattle Saturday, November 9, 2024, 15:00 Hr ...
Pharmabiz1d
Transgene & NEC to present new data confirming clinical proof of principle for neoantigen cancer vaccine, TG4050, in head & neck cancer at SITC 2024
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and AI technologies, announced 24.1 month ...